{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:28:54Z","timestamp":1791250134293,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry & Biology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.chembiol.2009.12.011","type":"journal-article","created":{"date-parts":[[2010,1,29]],"date-time":"2010-01-29T06:59:50Z","timestamp":1264748390000},"page":"46-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant"],"prefix":"10.1016","volume":"17","author":[{"given":"Nicolas","family":"Basse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel L.","family":"Kaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Settanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas C.","family":"Joerger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Fersht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2009.12.011_bib1","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.chembiol.2009.12.011_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1359-0278(97)00024-2","article-title":"Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potential","volume":"2","author":"Bahar","year":"1997","journal-title":"Fold. Des."},{"key":"10.1016\/j.chembiol.2009.12.011_bib3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/bi9720641","article-title":"Correlation between native-state hydrogen exchange and cooperative residue fluctuations from a simple model","volume":"37","author":"Bahar","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2009.12.011_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1006\/jmbi.1998.2371","article-title":"Collective motions in HIV-1 reverse transcriptase: examination of flexibility and enzyme function","volume":"285","author":"Bahar","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chembiol.2009.12.011_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drudis.2008.11.007","article-title":"Ligand efficiency and fragment-based drug discovery","volume":"14","author":"Bembenek","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.chembiol.2009.12.011_bib6","doi-asserted-by":"crossref","first-page":"10360","DOI":"10.1073\/pnas.0805326105","article-title":"Targeted rescue of a destabilized mutant of p53 by an in\u00a0silico screened drug","volume":"105","author":"Boeckler","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.12.011_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cbic.200301023","article-title":"Fluorine in medicinal chemistry","volume":"5","author":"Bohm","year":"2004","journal-title":"ChemBioChem"},{"key":"10.1016\/j.chembiol.2009.12.011_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"Charmm\u2014a program for macromolecular energy, minimization, and dynamics calculations","volume":"4","author":"Brooks","year":"1983","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.chembiol.2009.12.011_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/35094077","article-title":"Rescuing the function of mutant p53","volume":"1","author":"Bullock","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chembiol.2009.12.011_bib10","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1073\/pnas.94.26.14338","article-title":"Thermodynamic stability of wild-type and mutant p53 core domain","volume":"94","author":"Bullock","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.12.011_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.onc.1203434","article-title":"Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy","volume":"19","author":"Bullock","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2009.12.011_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0302-282","article-title":"Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound","volume":"8","author":"Bykov","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2009.12.011_bib13","doi-asserted-by":"crossref","first-page":"30384","DOI":"10.1074\/jbc.M501664200","article-title":"Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs","volume":"280","author":"Bykov","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2009.12.011_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.copbio.2007.09.003","article-title":"Fragment-based approaches to enzyme inhibition","volume":"18","author":"Ciulli","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.chembiol.2009.12.011_bib15","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S1359-6446(03)02831-9","article-title":"A rule of three for fragment-based lead discovery?","volume":"8","author":"Congreve","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.chembiol.2009.12.011_bib16","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1073\/pnas.0711209105","article-title":"High-resolution structures of HIV-1 reverse transcriptase\/TMC278 complexes: strategic flexibility explains potency against resistance mutations","volume":"105","author":"Das","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.12.011_bib17","doi-asserted-by":"crossref","first-page":"W375","DOI":"10.1093\/nar\/gkm216","article-title":"MolProbity: all-atom contacts and structure validation for proteins and nucleic acids","volume":"35","author":"Davis","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2009.12.011_bib18","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1073\/pnas.062398499","article-title":"Computational mapping identifies the binding sites of organic solvents on proteins","volume":"99","author":"Dennis","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.12.011_bib19","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/sj.onc.1202041","article-title":"Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay","volume":"16","author":"Di Como","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2009.12.011_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.copbio.2006.10.007","article-title":"Fragment-based lead discovery: a chemical update","volume":"17","author":"Erlanson","year":"2006","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.chembiol.2009.12.011_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1107\/S0907444905036693","article-title":"Scaling and assessment of data quality","volume":"62","author":"Evans","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.chembiol.2009.12.011_bib22","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1126\/science.286.5449.2507","article-title":"Pharmacological rescue of mutant p53 conformation and function","volume":"286","author":"Foster","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2009.12.011_bib23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1073\/pnas.241629998","article-title":"A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants","volume":"99","author":"Friedler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.12.011_bib24","doi-asserted-by":"crossref","first-page":"24108","DOI":"10.1074\/jbc.M302458200","article-title":"Kinetic instability of p53 core domain mutants: implications for rescue by small molecules","volume":"278","author":"Friedler","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2009.12.011_bib25","doi-asserted-by":"crossref","first-page":"e1000435","DOI":"10.1371\/journal.pcbi.1000435","article-title":"Computational fragment-based binding site identification by ligand competitive saturation","volume":"5","author":"Guvench","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.chembiol.2009.12.011_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrd2220","article-title":"A decade of fragment-based drug design: strategic advances and lessons learned","volume":"6","author":"Hajduk","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2009.12.011_bib27","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/jm9703404","article-title":"NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein","volume":"40","author":"Hajduk","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chembiol.2009.12.011_bib28","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1021\/jm049131r","article-title":"Druggability indices for protein targets derived from NMR-based screening data","volume":"48","author":"Hajduk","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chembiol.2009.12.011_bib29","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S1359-6446(05)03624-X","article-title":"Predicting protein druggability","volume":"10","author":"Hajduk","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.chembiol.2009.12.011_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng0395-221","article-title":"The dominating effect of mutant p53","volume":"9","author":"Hann","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2009.12.011_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.chembiol.2009.12.011_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2009.12.011_bib33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0022-2836(92)90557-Z","article-title":"Co-operative interactions during protein folding","volume":"224","author":"Horovitz","year":"1992","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chembiol.2009.12.011_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.chembiol.2009.12.011_bib35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jmb.2007.09.042","article-title":"Characterization and further stabilization of designed ankyrin repeat proteins by combining molecular dynamics simulations and experiments","volume":"375","author":"Interlandi","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chembiol.2009.12.011_bib36","doi-asserted-by":"crossref","first-page":"13303","DOI":"10.1073\/pnas.1835733100","article-title":"Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide","volume":"100","author":"Issaeva","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.12.011_bib37","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/sj.onc.1210291","article-title":"Structure-function-rescue: the diverse nature of common p53 cancer mutants","volume":"26","author":"Joerger","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.chembiol.2009.12.011_bib38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","article-title":"Structural biology of the tumor suppressor p53","volume":"77","author":"Joerger","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.chembiol.2009.12.011_bib39","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1074\/jbc.M309732200","article-title":"Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations","volume":"279","author":"Joerger","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2009.12.011_bib40","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1073\/pnas.0607286103","article-title":"Structural basis for understanding oncogenic p53 mutations and designing rescue drugs","volume":"103","author":"Joerger","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.12.011_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.molcel.2006.05.015","article-title":"Structural basis of DNA recognition by p53 tetramers","volume":"22","author":"Kitayner","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2009.12.011_bib42","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ccr.2009.03.003","article-title":"PRIMA-1 reactivates mutant p53 by covalent binding to the core domain","volume":"15","author":"Lambert","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2009.12.011_bib43","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1107\/S090744499900846X","article-title":"Integration of macromolecular diffraction data","volume":"55","author":"Leslie","year":"1999","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.chembiol.2009.12.011_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","article-title":"The p53 tumour suppressor gene","volume":"351","author":"Levine","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2009.12.011_bib45","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nbt0397-264","article-title":"Organic solvents identify specific ligand binding sites on protein surfaces","volume":"15","author":"Liepinsh","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2009.12.011_bib46","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics studies of proteins","volume":"102","author":"MacKerell","year":"1998","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.chembiol.2009.12.011_bib47","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/anie.200390233","article-title":"NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors","volume":"42","author":"Meyer","year":"2003","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.chembiol.2009.12.011_bib48","doi-asserted-by":"crossref","first-page":"14675","DOI":"10.1073\/pnas.95.25.14675","article-title":"Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability","volume":"95","author":"Nikolova","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.12.011_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mc.10038","article-title":"Restoration of wild-type conformation and activity of a temperature-sensitive mutant of p53 (p53(V272M)) by the cytoprotective aminothiol WR1065 in the esophageal cancer cell line TE-1","volume":"33","author":"North","year":"2002","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.chembiol.2009.12.011_bib50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"Petitjean","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.chembiol.2009.12.011_bib51","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.chembiol.2009.12.011_bib52","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1021\/jm801385d","article-title":"Binding site detection and druggability index from first principles","volume":"52","author":"Seco","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.chembiol.2009.12.011_bib53","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/bioinformatics\/btm378","article-title":"Wordom: a program for efficient analysis of molecular dynamics simulations","volume":"23","author":"Seeber","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.chembiol.2009.12.011_bib54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrd1129","article-title":"Implications of protein flexibility for drug discovery","volume":"2","author":"Teague","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2009.12.011_bib55","doi-asserted-by":"crossref","first-page":"18908","DOI":"10.1073\/pnas.0507603102","article-title":"Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state","volume":"102","author":"Tobi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2009.12.011_bib56","unstructured":"Turk, D. (1992). PhD thesis. Technische Universit\u00e4t M\u00fcnchen, Munich, Germany."},{"key":"10.1016\/j.chembiol.2009.12.011_bib57","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","article-title":"p53 in health and disease","volume":"8","author":"Vousden","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.chembiol.2009.12.011_bib58","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkl084","article-title":"oGNM: online computation of structural dynamics using the Gaussian Network Model","volume":"34","author":"Yang","year":"2006","journal-title":"Nucleic Acids Res."}],"container-title":["Chemistry & Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107455210900444X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107455210900444X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:14:24Z","timestamp":1761030864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107455210900444X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S107455210900444X"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2009.12.011","relation":{},"ISSN":["1074-5521"],"issn-type":[{"value":"1074-5521","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant","name":"articletitle","label":"Article Title"},{"value":"Chemistry & Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2009.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}